Publications: Dr Neil McCafferty
Mencel J, Turkes F, Barber L, Challoner B, Buzzetti M, Tran A, Chen H, McCafferty N et al.
(
2023
)
.
P-111 PD1 and LAG3 inhibition as second+ line treatment after EGFR antibody-containing therapy in RAS/BRAF wildtype, MMRp metastatic colorectal cancer
.
Annals of Oncology
vol.
34
,
s53
-
s54
.
McCafferty N, Fong C, Barber LJ, Woolston A, Kleftogiannis D, Rana T, Cromarty S, Kidd S et al.
(
2023
)
.
Abstract 5593: Clonal mutation burden and evolutionary dynamics analysis in metastatic gastro-esophageal adenocarcinoma (GEA) by error corrected whole-exome circulating tumor DNA sequencing
.
Cancer Research
vol.
83
,
(
7_Supplement
)
5593
-
5593
.
McCafferty N, Stewart JP, Darzentas N, Gazdova J, Catherwood M, Stamatopoulos K, Langerak AW, Gonzalez D
(
2022
)
.
A novel next-generation sequencing capture-based strategy to report somatic hypermutation status using genomic regions downstream to immunoglobulin rearrangements
.
Haematologica
vol.
108
,
(
5
)
1313
-
1321
.